Epic vs. Health Gorilla: The battle over who controls your health data

Epic's lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing.

Editor's Pick

Top Story Epic vs. Health Gorilla: Inside the Battle Over Who Controls Your Medical Records Epic's lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing. Sponsored How Can AI Support Dental Service Organizations? Presented by Overjet There is a growing demand for advanced technology integration, such as AI tools for clinical decision support, for example, to improve patient care and DSO efficiency.  Get insights on how DSO can benefit with Overjet's AI applications. Click here to learn more.

Featured News

Health Tech Vendor Due Diligence: A HIPAA Security Guide for Medical Practices [Sponsored] A white paper from RingCentral shares the different types of questions and steps in this process that medical practices should consider, What Maven Clinic Hopes to Achieve With Its New Research Institute Maven Clinic launched a research institute to build and share evidence on the impact of digital care for women and families. What if Oprah Knew About Fractyl Health? People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick? Presbyopia Eye Drop From Startup Tenpoint Gets FDA Approval, Paving Way for $235M Financing Tenpoint Therapeutics' Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and AbbVie. Yuvezzi's commercialization will be supported by up to $235 million in financing. The 96-Hour Advantage: Why Early Diagnostic Accuracy Defines Clinical Outcomes Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control.

Video   Video: Inside a New Recursion Drug Katie Couric lost her husband to colon cancer in 1998. Nearly 30 years later, colon cancer rates are rising sharply, especially among younger people, and scientists still don't fully understand why. Watch Couric chat with Najat Khan, CEO of Recursion Pharmaceuticals. Recursion is using AI to identify a promising compound that targets the underlying biology of the disease.

Sponsored Omaha ABA Therapy: Comparing the Top Providers Presented by Stride Autism Centers The right provider enables children to gain confidence, learn to express their needs and discover new ways to connect with the world around them. Learn More

Resources

sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion In a recent interview, Esperion President and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company's expansion into new diseases. Read more

MedCity News • PO Box 901 • New York, NY unsubscribe